Pfizer close to $7.3 bln takeover of weight loss drugmaker Metsera- FT
PositiveFinancial Markets
Pfizer is reportedly nearing a $7.3 billion acquisition of Metsera, a company specializing in weight loss medications. This move highlights Pfizer's commitment to expanding its portfolio in the growing health and wellness sector, particularly as demand for effective weight management solutions continues to rise. The acquisition could enhance Pfizer's market position and provide new opportunities for innovation in obesity treatment.
— Curated by the World Pulse Now AI Editorial System